| |
| |
|
| Insider
Information: |
Bienaime Jean Jacques |
| Relationship: |
|
| City: |
Palo Alto |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
539,854 |
|
|
Indirect Shares
|
247,533 |
|
|
| Direct
Value |
$43,056,670 |
|
|
|
Indirect Value
|
$21,938,850 |
|
|
| Total
Shares |
787,387 |
|
|
| Total
Value |
$64,995,519 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
1
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
1
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
 -13.1%
|
-5.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2024-05-20 |
473,792 |
2024-05-20 |
247,533 |
Premium* |
|
|
Neurogesx Inc |
NGSX |
Director |
2011-07-26 |
21,748 |
|
0 |
Premium* |
|
|
InterMune Inc |
ITMN |
Director |
2014-09-29 |
0 |
2012-04-06 |
0 |
Premium* |
|
|
Portola Pharmaceuticals Inc |
PTLA |
Director |
2014-05-16 |
706 |
2013-05-28 |
0 |
Premium* |
|
|
Immunic Inc |
IMUX |
Director |
2018-09-24 |
18,500 |
2001-04-23 |
0 |
Premium* |
|
|
Incyte Corp |
INCY |
Director |
2023-06-14 |
15,493 |
|
0 |
Premium* |
|
|
Immunome Inc. |
IMNM |
|
2024-05-21 |
9,615 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
852 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 35
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2014-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
78,750 |
194,520 |
0 |
- |
|
| IMUX |
Immunic Inc |
Director |
– • – |
2014-04-23 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
20,833 |
0 |
- |
|
| ITMN |
InterMune Inc |
Director |
– • – |
2014-05-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,000 |
9,725 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2014-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
50,900 |
229,157 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2014-07-31 |
5 |
GD |
$0.00 |
$0 |
D/D |
1,000 |
226,157 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2014-10-29 |
5 |
GA |
$0.00 |
$0 |
D/D |
7,011 |
233,168 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2014-10-29 |
5 |
GD |
$0.00 |
$0 |
I/I |
7,011 |
36,184 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2014-11-13 |
5 |
GD |
$0.00 |
$0 |
D/D |
2,400 |
230,768 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2015-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
39,600 |
254,757 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2015-04-17 |
5 |
GD |
$0.00 |
$0 |
D/D |
500 |
228,254 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2015-07-02 |
4 |
GD |
$0.00 |
$0 |
D/D |
500 |
228,754 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2016-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
315,228 |
543,482 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2016-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
60,710 |
392,221 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2016-08-03 |
4 |
GD |
$0.00 |
$0 |
D/D |
400 |
378,184 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2016-08-04 |
4 |
GD |
$0.00 |
$0 |
D/D |
500 |
377,684 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2016-08-24 |
4 |
GD |
$0.00 |
$0 |
D/D |
200 |
377,484 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2017-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
44,671 |
215,353 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2017-03-22 |
4 |
A |
$0.00 |
$0 |
D/D |
44,520 |
235,194 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2017-09-26 |
4 |
GD |
$0.00 |
$0 |
D/D |
430 |
226,494 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2017-12-14 |
4/A |
GD |
$0.00 |
$0 |
I/I |
600 |
182,201 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2017-12-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
600 |
225,894 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2018-02-26 |
4/A |
A |
$0.00 |
$0 |
D/D |
46,034 |
272,528 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2018-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
45,722 |
272,216 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2018-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
46,340 |
296,106 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2018-11-19 |
4 |
GD |
$0.00 |
$0 |
I/I |
160 |
182,041 |
0 |
- |
|
852 Records found
|
|
Page 2 of 35 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
